C

Catalyst Biosciences Inc
F:HGF2

Watchlist Manager
Catalyst Biosciences Inc
F:HGF2
Watchlist
Price: 7.404 EUR 1 377.84% Market Closed
Market Cap: 279.6m EUR

Intrinsic Value

HGF2 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of HGF2.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HGF2 Intrinsic Value
Not Available
C
Base Case Scenario
Compare HGF2 to

Fundamental Analysis

Catalyst Biosciences Inc
F:HGF2
US
Biotechnology
Market Cap
279.6m EUR
IPO
Apr 12, 2006
US
Biotechnology
Market Cap
279.6m EUR
IPO
Apr 12, 2006
Price
€false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HGF2?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Catalyst Biosciences Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Catalyst Biosciences Inc

Balance Sheet Decomposition
Catalyst Biosciences Inc

Balance Sheet Decomposition is not available for
Catalyst Biosciences Inc
Efficiency

Free Cash Flow Analysis
Catalyst Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Catalyst Biosciences Inc

Revenue
794k USD
Cost of Revenue
-798k USD
Gross Profit
-4k USD
Operating Expenses
-29.4m USD
Operating Income
-29.4m USD
Other Expenses
21.2m USD
Net Income
-8.2m USD
Fundamental Scores

HGF2 Profitability Score
Profitability Due Diligence

Catalyst Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Negative Gross Profit
Negative 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
38/100
Profitability
Score

Catalyst Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

HGF2 Solvency Score
Solvency Due Diligence

Catalyst Biosciences Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
55/100
Solvency
Score

Catalyst Biosciences Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HGF2 Price Targets Summary
Catalyst Biosciences Inc

There are no price targets for HGF2.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HGF2 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y